Jalalon, Wilma A.
HRN: 27-82-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/21/2025
09/28/2025
IV
500
Q8
Liver Cirrhosis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes